The Portuguese Severe Asthma Registry (Registo de Asma Grave Portugal, RAG) was
developed by an open collaborative network of asthma specialists. RAG collects data from …

61 people suffering from persistent allergic rhinitis and asthma accompanying food allergies
were studied using case histories, the NHANES questionnaire, polyspecific serum levels …

Objective To assess socio-sanitary expenditure after the addition of omalizumab to standard
treatment in the control of severe asthma and to analyse its effectiveness under standard …

Severe asthma constitutes a serious health burden with significant morbidity and
socioeconomic costs. The development and introduction of new biologics targeting type 2 …

Регистры пациентов помогают получать актуальную информацию о клиническом
течении заболеваний, о безопасности и эффективности используемых медицинских …

Background The appropriate identification of asthma phenotypes of responders to
omalizumab would optimize the selection of treatment. Objective To describe the most …

Abstract Introduction Humanized monoclonal anti-IgE antibody (omalizumab) has
demonstrated efficacy in severe atopic asthma. However, few studies have assessed its …

В настоящее время применение анти-IgE-терапии (омализумаба) является
единственным фенотипспецифическим лечением тяжелой IgE-обусловленной …

Objective To provide an overview of primary and secondary mechanisms associated with
anti-IgE therapy and their relation to other potential indications in diseases affecting the …

sarrollo del trabajo de redacción se basó en un sistema de consenso piramidal: de
miniconsenso multidisciplinar temático por capítulo, a un gran consenso final entre todos los …